Determination of the particle size of the catiazine substance by laser difraction
DOI:
https://doi.org/10.24959/nphj.21.67Keywords:
cathiazine; substance; particle size distribution; laser diffractionAbstract
Aim. To determine the particle size distribution of the new original substance cathiazine by laser diffraction.
Materials and methods. The substance cathiazine was synthesized on the basis of d,l-camphoric acid and 2-aminothiazoline at the Institute of Endocrine Pathology Problems. The sperm-modulating effect of the new compound was proven in experimental animals. Its low toxicity at rather high efficiency was also confirmed. Determination of the particle
size of the powder of the substance cathiazine was performed by laser diffraction. The study was conducted on three laboratory batches. Optical microscopy was used to compare and confirm the results.
Results and discussion. It was found that the average median particle size of the powder of the substance cathiazine was: for batch 1 – 38 μm, for batch 2 – 33 μm, for batch 3 – 53 μm. The maximum size for 80 % of particles of batch 1 was 115 μm, batch 2 – 90 μm, batch 3 – 125 μm. Microphotographs of three batches of the substance cathiazine obtained by optical microscopy were presented. This method also confirmed that the size of the registered particles did not exceed 200 μm. This was in good agreement with the previous studies, in which the recommended average particle size should not exceed 100 μm, and the mass fraction of larger fractions was proposed to be controlled.
Conclusions. The particle size values of the powder substance cathiazine for three laboratory batches have been obtained. It has been found that the particle size and their size distribution in all laboratory batches of the substance cathiazine do not differ significantly. The data obtained can be used to normalize particle sizes in technology when
developing drugs
References
- Фармакопейные методы определения размера частиц. Метод лазерной дифракции света в контроле гетерогенности лекарственных средств / Е. В. Успенская и др. Health and Education Millennium. 2016. Т. 18, № 9. P. 112–114.
- Дослідження розміру та форми частинок лізиноприлу дигідрату та допоміжних речовин з метою отримання оптимальних фармакотехнологічних властивостей маси для таблетування / О. О. Салій та ін. Український біофармацевтичний журнал. 2019. №. 4 (61). Р. 9–16. DOI: https://doi.org/10.24959/ubphj.19.242.
- Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective Saturday / Zhigang Sun et al. American Pharmaceutical Review. 2010. URL: https://bit.ly/3m5TU0W.
- ОФС.1.2.1.0008.15 Определение распределения частиц по размеру методом лазерной дифракции света. URL: https://pharmacopoeia.ru/ofs-1-2-1-0008-15-opredelenie-raspredeleniya-chastits-po-razmeru-metodom-lazernoj-difraktsii-sveta/.
- 2.9.31 Визначення розміру частинок методом лазерної дифракції / ДП «Український науковий фармакопейний центр якості лікарських засобів». Державна Фармакопея України : в 3 т. 2–е вид. Харків : ДП «Український науковий фармакопейний центр якості лікарських засобів», 2015. Т. 1. С. 458.
- 3 (4,5-дигідротіазол-2-іл) амід цис-1,2,2-триметилциклопентан-1,3-дикарбонової кислоти, що стимулює : пат. 38130 Україна. № u 2000063139 ; заявл. 01.06.00 ; опубл. 13.05.01, Бюл. № 4. С. 159.
- Зависимость растворимости фенсукцинала от размера частиц / А. И. Гризодуб и др. Фармаком. 2008. № 1. С. 50–67.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 National University of Pharmacy

This work is licensed under a Creative Commons Attribution 4.0 International License.
